These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29246154)

  • 1. Dexamethasone implants in paediatric patients with noninfectious intermediate or posterior uveitis: first prospective exploratory case series.
    Winterhalter S; Behrens UD; Salchow D; Joussen AM; Pleyer U
    BMC Ophthalmol; 2017 Dec; 17(1):252. PubMed ID: 29246154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.
    Lowder C; Belfort R; Lightman S; Foster CS; Robinson MR; Schiffman RM; Li XY; Cui H; Whitcup SM;
    Arch Ophthalmol; 2011 May; 129(5):545-53. PubMed ID: 21220619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience.
    Pohlmann D; Vom Brocke GA; Winterhalter S; Steurer T; Thees S; Pleyer U
    Ophthalmology; 2018 Jul; 125(7):1088-1099. PubMed ID: 29459041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.
    Sella R; Oray M; Friling R; Umar L; Tugal-Tutkun I; Kramer M
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1777-82. PubMed ID: 26228441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Treating Pediatric Uveitis With Dexamethasone Implants.
    Tomkins-Netzer O; Talat L; Seguin-Greenstein S; Bar A; Lightman S
    Am J Ophthalmol; 2016 Jan; 161():110-5.e1-2. PubMed ID: 26478217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis.
    Palla S; Biswas J; Nagesha CK
    Indian J Ophthalmol; 2015 Oct; 63(10):767-70. PubMed ID: 26655000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal steroids for macular edema in diabetes.
    Rittiphairoj T; Mir TA; Li T; Virgili G
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
    Jaffe GJ; Lin P; Keenan RT; Ashton P; Skalak C; Stinnett SS
    Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    ; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
    Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis.
    Tomkins-Netzer O; Taylor SR; Bar A; Lula A; Yaganti S; Talat L; Lightman S
    Ophthalmology; 2014 Aug; 121(8):1649-54. PubMed ID: 24650556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jiao J; Li XY; Whitcup SM; ; Li J
    Ophthalmology; 2011 Dec; 118(12):2453-60. PubMed ID: 21764136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.
    Li X; Wang N; Liang X; Xu G; Li XY; Jiao J; Lou J; Hashad Y;
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):59-69. PubMed ID: 29119239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
    ; Kempen JH; Altaweel MM; Holbrook JT; Jabs DA; Louis TA; Sugar EA; Thorne JE
    Ophthalmology; 2011 Oct; 118(10):1916-26. PubMed ID: 21840602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
    Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
    Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
    Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis.
    Hasanreisoğlu M; Özdemir HB; Özkan K; Yüksel M; Aktaş Z; Atalay HT; Özdek Ş; Gürelik G
    Turk J Ophthalmol; 2019 Oct; 49(5):250-257. PubMed ID: 31650791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal Dexamethasone Implant for Treatment of Refractory Behçet Posterior Uveitis: One-year Follow-up Results.
    Coşkun E; Celemler P; Kimyon G; Öner V; Kisacik B; Erbagci I; Onat AM
    Ocul Immunol Inflamm; 2015; 23(6):437-43. PubMed ID: 26470764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.